# Commission Regulation (EC) No 1662/95 of 7 July 1995 laying down certain detailed arrangements for implementing the Community decision-making procedures in respect of marketing authorizations for products for human or veterinary use, Article 2

Extent: E+W+S+N.I.

Matters shall be referred to the Committee by the chairman pursuant to the relevant provisions of Regulation (EEC) No 2309/93, Directive 75/319/EEC or Directive 81/851/EEC.
Except in exceptional cases where the draft decision prepared by the Commission is not in accordance with the opinion of the European Agency for the Evaluation of Medicinal Products, a written procedure shall be used as described in Article 3.

---
Source: https://www.legislation.gov.uk/eur/1995/1662/article/2 (the official version)
Page: https://openlegislation.uk/eu-regulation-1995-1662/article-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.